Home/Filings/4/0001483813-13-000015
4//SEC Filing

Frost Gregory Ian 4

Accession 0001483813-13-000015

CIK 0001159036other

Filed

Feb 4, 7:00 PM ET

Accepted

Feb 5, 8:23 PM ET

Size

6.7 KB

Accession

0001483813-13-000015

Insider Transaction Report

Form 4
Period: 2013-02-02
Frost Gregory Ian
DirectorVP and Chief Scientific Off.
Transactions
  • Exercise/Conversion

    Common Stock

    2013-02-02+11,3123,566,643 total
  • Exercise/Conversion

    Common Stock

    2013-02-02+4,7373,571,380 total
Footnotes (2)
  • [F1]Represents net settlement for the vesting of 19,213 shares of a restricted stock unit award granted in February 2012. Upon vesting of these units on February 2, 2013, the reporting person received a settlement of 11,312 shares of Halozyme common stock. 7,901 shares were withheld as payment for minimum statutory tax withholding requirements.
  • [F2]Represents net settlement for the vesting of 7,500 shares of another restricted stock unit award granted in February 2012. Upon vesting of these units on February 2, 2013, the reporting person received a settlement of 4,737 shares of Halozyme common stock. 2,763 shares were withheld as payment for minimum statutory tax withholding requirements.

Issuer

HALOZYME THERAPEUTICS INC

CIK 0001159036

Entity typeother

Related Parties

1
  • filerCIK 0001283518

Filing Metadata

Form type
4
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 8:23 PM ET
Size
6.7 KB